Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
Tweet
Share
E-mailGet Alerts PTHS Hot Sheet
Join SI Premium – FREE
Pelthos Therapeutics Inc. (NYSE: PTHS) reported Q2 EPS of ($6.62), $6.11 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $15.6 million.
For earnings history and earnings-related data on Pelthos Therapeutics Inc. (PTHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tenable Holdings, Inc. (TENB) to Join S&P SmallCap 600
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- HP Inc. (HPQ) Tops Q3 EPS by 17c, Beats on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
